Treatment of Immune-related Adverse Events Refractory to Standard Therapy and Associated Changes in Immunophenotype

Clinical trial NCT05700565 · RECRUITING

Trial details

NCT number: NCT05700565
Sponsor: Lucie Heinzerling
Status: RECRUITING
Study type: OBSERVATIONAL

Immune-related Adverse Event

Start date: 2022-01-01
Primary completion: 2027-01-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.